Medicine Grand Rounds: “Reimagining Food Allergy Management: New Therapies and Future Possibilites” Presented by David Fleischer, MD, Section Head of Pediatrics Allergy and Immunology, Director and Professor of the Pediatrics Allergy and Immunology Center, University of Colorado Anschutz Medical Campus. 

Join us in person! Bruce Schroffel Auditorium, University of Colorado Hospital, Anschutz Inpatient Pavilion 2, First Floor Conference Room – Lunch Provided
or via Zoom.

Learning Objectives:

• Distinguish IgE-mediated food allergy from other forms of food allergy and food intolerance
• Review current and future food allergy treatments
• Review current and future treatments for anaphylaxis 

Disclosure Statement: ​​​​​​Dr. Fleischer reports a financial relationship as a consultant for Aquestive, ARS Pharma, DBV Technologies, Genetech Nasus Pharma, Phylaxis. As well as a research support to ALK, Aquestive, ARS Pharma, DBV Technologies. Also, stock options in Grow Happy and Nasus Pharma. All of the relevant financial relationships listed for this individual have been mitigated. All of the other planners, faculty, or individuals in control of content for this educational activity have no relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

ABIM MOC Statement: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1 MOC point in the American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit information to ACGME for the purpose of granting ABIM MOC credit.

Accreditation & Designation Statement: The University of Colorado School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The University of Colorado School of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.